Impax Laboratories, Inc. - Product Pipeline Review - 2014

1 of 3
Impax Laboratories, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Impax Laboratories, Inc. - Product Pipeline Review - 2014’, provides an overview of the Impax Laboratories, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Impax Laboratories, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Impax Laboratories, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Impax Laboratories, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Impax Laboratories, Inc.’s pipeline products

Reasons to buy

- Evaluate Impax Laboratories, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Impax Laboratories, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Impax Laboratories, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Impax Laboratories, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Impax Laboratories, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Impax Laboratories, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Table of Contents
Table of Contents
List of Tables
List of Figures
Impax Laboratories, Inc. Snapshot
Impax Laboratories, Inc. Overview
Key Information
Key Facts
Impax Laboratories, Inc. - Research and Development Overview
Key Therapeutic Areas
Impax Laboratories, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Impax Laboratories, Inc. - Pipeline Products Glance
Impax Laboratories, Inc. - Late Stage Pipeline Products
Filing rejected/Withdrawn Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Impax Laboratories, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Impax Laboratories, Inc. - Drug Profiles
(carbidopa + levodopa)
Product Description
Mechanism of Action
R&D Progress
bupivacaine Patch
Product Description
Mechanism of Action
R&D Progress
IPX-203
Product Description
Mechanism of Action
R&D Progress
IPX-218
Product Description
Mechanism of Action
R&D Progress
IPX-231
Product Description
Mechanism of Action
R&D Progress
IPX-232
Product Description
Mechanism of Action
R&D Progress
IPX-233
Product Description
Mechanism of Action
R&D Progress
IPX-237
Product Description
Mechanism of Action
R&D Progress
Impax Laboratories, Inc. - Pipeline Analysis
Impax Laboratories, Inc. - Pipeline Products by Target
Impax Laboratories, Inc. - Pipeline Products by Route of Administration
Impax Laboratories, Inc. - Pipeline Products by Molecule Type
Impax Laboratories, Inc. - Pipeline Products by Mechanism of Action
Impax Laboratories, Inc. - Recent Pipeline Updates
Impax Laboratories, Inc. - Dormant Projects
Impax Laboratories, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
IPX-159
Impax Laboratories, Inc. - Company Statement
Impax Laboratories, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Impax Laboratories, Inc., Key Information
Impax Laboratories, Inc., Key Facts
Impax Laboratories, Inc. - Pipeline by Indication, 2014
Impax Laboratories, Inc. - Pipeline by Stage of Development, 2014
Impax Laboratories, Inc. - Monotherapy Products in Pipeline, 2014
Impax Laboratories, Inc. - Combination Treatment Modalities in Pipeline, 2014
Impax Laboratories, Inc. - Filing rejected/Withdrawn, 2014
Impax Laboratories, Inc. - Phase III, 2014
Impax Laboratories, Inc. - Phase II, 2014
Impax Laboratories, Inc. - Phase I, 2014
Impax Laboratories, Inc. - Pipeline by Target, 2014
Impax Laboratories, Inc. - Pipeline by Route of Administration, 2014
Impax Laboratories, Inc. - Pipeline by Molecule Type, 2014
Impax Laboratories, Inc. - Pipeline Products by Mechanism of Action, 2014
Impax Laboratories, Inc. - Recent Pipeline Updates, 2014
Impax Laboratories, Inc. - Dormant Developmental Projects,2014
Impax Laboratories, Inc. - Discontinued Pipeline Products, 2014
Impax Laboratories, Inc., Other Locations
Impax Laboratories, Inc., Subsidiaries

List of Figures
Impax Laboratories, Inc. - Pipeline by Top 10 Indication, 2014
Impax Laboratories, Inc. - Pipeline by Stage of Development, 2014
Impax Laboratories, Inc. - Monotherapy Products in Pipeline, 2014
Impax Laboratories, Inc. - Combination Treatment Modalities in Pipeline, 2014
Impax Laboratories, Inc. - Pipeline by Top 10 Target, 2014
Impax Laboratories, Inc. - Pipeline by Top 10 Route of Administration, 2014
Impax Laboratories, Inc. - Pipeline by Top 10 Molecule Type, 2014
Impax Laboratories, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 28
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll